Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity.

[1]  Z. Darżynkiewicz,et al.  Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure–function relationship , 1999, Cell proliferation.

[2]  M. Kaksonen,et al.  Cortactin-Src Kinase Signaling Pathway Is Involved in N-syndecan-dependent Neurite Outgrowth* , 1998, The Journal of Biological Chemistry.

[3]  N. Karamanos,et al.  Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. , 1997, Biochimie.

[4]  A. Woods,et al.  Multimerization of the Cytoplasmic Domain of Syndecan-4 Is Required for Its Ability to Activate Protein Kinase C* , 1997, The Journal of Biological Chemistry.

[5]  J. Olsen,et al.  Retroviral Gene Transfer Is Inhibited by Chondroitin Sulfate Proteoglycans/Glycosaminoglycans in Malignant Pleural Effusions* , 1997, The Journal of Biological Chemistry.

[6]  A. Woods,et al.  Syndecan-4 Proteoglycan Regulates the Distribution and Activity of Protein Kinase C* , 1997, The Journal of Biological Chemistry.

[7]  N. Karamanos,et al.  Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. , 1997, Journal of chromatography. A.

[8]  A. Hjerpe,et al.  Effect of insulin and epidermal growth factors on the synthesis of glycosaminoglycans/proteoglycans in cultured human malignant mesothelioma cells of different phenotypic morphology , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[9]  A. Hjerpe,et al.  Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. , 1995, Experimental cell research.

[10]  A. Ghahary,et al.  Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor‐β in human post‐burn hypertrophic and mature scars , 1995, Histopathology.

[11]  N. Karamanos,et al.  Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. , 1995, Journal of chromatography. A.

[12]  T. Roskams,et al.  Heparan sulfate proteoglycan expression in normal human liver , 1995, Hepatology.

[13]  M. Jalkanen,et al.  Function of the syndecans--a family of cell surface proteoglycans. , 1994, Journal of cell science.

[14]  N. Karamanos,et al.  Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. , 1994, Analytical biochemistry.

[15]  P. Heldin,et al.  Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. , 1994, Cancer research.

[16]  R. Iozzo.  Perlecan: a gem of a proteoglycan. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[17]  P. Heldin,et al.  Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. , 1993, Cancer research.

[18]  William Arbuthnot Sir Lane,et al.  Isolation of a large aggregating proteoglycan from human brain. , 1992, The Journal of biological chemistry.

[19]  E. Qwarnstrom,et al.  The role of proteoglycans in cell adhesion, migration and proliferation. , 1992 .

[20]  Nikos Karamanos.  Two squid skin proteoglycans each containing chondroitin sulfates with different sulfation patterns. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[21]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  S. Aaronson,et al.  Growth factors and cancer. , 1991, Science.

[23]  S. Barnes,et al.  Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. , 1991, Biochemical and biophysical research communications.

[24]  T. Tsukamoto,et al.  [Study on in vitro invasive potential of renal cell carcinoma cell lines and effect of growth factors (EGF and TGF-beta 1) on their in invasions]. , 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[25]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[26]  Michael Cross,et al.  Growth factors in development, transformation, and tumorigenesis , 1991, Cell.

[27]  J. Trevillyan,et al.  Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase. , 1990, Journal of immunology.

[28]  A. Hjerpe,et al.  Chondroitin proteoglycans from squid skin. Isolation, characterization and immunological studies. , 1990, European journal of biochemistry.

[29]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[30]  A. Pardee.  G1 events and regulation of cell proliferation. , 1989, Science.

[31]  G. Gahrton,et al.  Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. , 1989, Cancer research.

[32]  T. Watanabe,et al.  Inhibitors for protein-tyrosine kinases, ST638 and genistein: induce differentiation of mouse erythroleukemia cells in a synergistic manner. , 1989, Experimental cell research.

[33]  J. Cassiman,et al.  Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblasts. , 1989, The Journal of biological chemistry.

[34]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[35]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[36]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[37]  T. Yamagata,et al.  Purification and properties of bacterial chondroitinases and chondrosulfatases. , 1968, The Journal of biological chemistry.

[38]  Nikos Karamanos.  Proteoglycans: Biological Roles and Strategies for Isolation and Determination of Their Glycan Constituents , 2000 .

[39]  T. Choli-Papadopoulou,et al.  Proteome and Protein Analysis , 2000, Springer Berlin Heidelberg.

[40]  A. Hjerpe,et al.  High performance capillary electrophoresis method to characterize heparin and heparan sulfate disaccharides , 1996, Electrophoresis.

[41]  N. Karamanos,et al.  Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[42]  A. Honda,et al.  Cooperative enhancement of hyaluronic acid synthesis by combined use of IGF-I and EGF, and inhibition by tyrosine kinase inhibitor genistein, in cultured mesothelial cells from rabbit pericardial cavity. , 1991, Journal of cell science.

[43]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.

[44]  A. Linker,et al.  [123] Heparinase and heparitinase from flavobacteria , 1972 .